Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Cognitive decline is natural: it starts to subtly set in by our 40s, and by your mid-50s it’s perfectly normal to find ...

Pixel users can now open apps faster with the keyboard's enter key, instead of tapping the app icon.

People across the globe, especially in low-income countries, continue to use solid fuels like coal, wood and plant waste for ...

Silent cells deep in your spinal cord may hold a surprising key to healing after devastating injuries and brain disease. A ...

At the New Mexico History Museum, artist Molly Mendenhall's mural commemorates the centennial of Route 66, capturing its ...

Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes ('T2D”) and in T2D patients currently failing ...

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced preliminary unaudited fourth ...

Previous research links tiny plastic particles to a range of adverse health conditions but largely stops short of ...

Research on adults 60-70 years old showed that after 16 weeks, participants who swam regularly showed significant ...

The NHS has warned that vitamin B12 deficiency can cause neurological problems that may mimic dementia symptoms ...

Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body ...